Endometrial tissue proliferation

Endometrial tissue proliferation refers to the cyclic growth and multiplication of endometrial cells under the influence of ovarian steroids—primarily estrogen and progesterone—as well as growth factors such as EGF, IGF, and others[3][7]. Proliferation is essential for normal uterine function and fertility, but dysregulation can lead to various pathologies including endometriosis, hyperplasia, and cancer[3][5][7]. The process is mediated through the activation of signaling pathways including PI3K/Akt, Wnt/β-catenin, and JAK/STAT, as well as regulation by hormone receptors (estrogen and progesterone receptors)[1][5][7]. While not a molecular target itself, endometrial tissue proliferation is a key endpoint or readout in evaluating the effectiveness of treatments acting through these molecular pathways. Endometrial tissue proliferation is therefore accurately described as a biological process, not a drug target, and is not a canonical molecule, receptor, or protein suitable for traditional drug targeting. It is important for users to instead identify specific signaling molecules (such as "Estrogen receptor" or "PI3K/Akt pathway") if detailed target-level pharmacological information is needed[1][3][5][7].

Other names

Endometrial cell proliferationEndometrial growthProliferation of endometrial tissue